Literature DB >> 20400863

Therapeutic antibodies, vaccines and antibodyomes.

Dimiter S Dimitrov1.   

Abstract

The potential for antibodies to act as "magic bullets" for treatment of human disease was recognized a century ago, but its full realization has began to occur only during the last decade. A key to their current success is the ability to make libraries of antibodies/B cells, isolate a single species, and engineer it to be safe, efficacious and of high quality. Despite this progress, major challenges to the effective prevention, diagnosis and treatment of a vast majority of diseases remain. Limited success in the development of effective vaccines against diseases such as AIDS and cancer reflects our incomplete understanding of how antibodies are generated and function. Only a miniscule number of antibodies are characterized out of the universe of antibodies generated by the immune system. Knowledge of antibodyomes-the complete sets of antibodies-could help solve these and other challenges.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400863      PMCID: PMC2881260          DOI: 10.4161/mabs.2.3.11779

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  82 in total

1.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 2.  Monoclonal antibodies as innovative therapeutics.

Authors:  Janice M Reichert
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

Review 3.  Challenges in monoclonal antibody-based therapies.

Authors:  Haritha Samaranayake; Thomas Wirth; Diana Schenkwein; Jani K Räty; Seppo Ylä-Herttuala
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

Review 4.  Preclinical efficacy and safety models for mAbs: the challenge of developing effective model systems.

Authors:  Rakesh Dixit; Steve Coats
Journal:  IDrugs       Date:  2009-02

Review 5.  Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates.

Authors:  Anne S De Groot; Julie McMurry; Lenny Moise
Journal:  Curr Opin Pharmacol       Date:  2008-09-19       Impact factor: 5.547

Review 6.  When binding is enough: nonactivating antibody formats.

Authors:  Aran F Labrijn; Rob C Aalberse; Janine Schuurman
Journal:  Curr Opin Immunol       Date:  2008-07-09       Impact factor: 7.486

Review 7.  Monoclonal antibody therapies for solid tumors.

Authors:  Dimiter V Tassev; Nai-Kong V Cheung
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

8.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

Review 9.  Monoclonal antibody therapy for prostate cancer.

Authors:  A Jakobovits
Journal:  Handb Exp Pharmacol       Date:  2008

10.  Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors:  Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

View more
  81 in total

1.  Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.

Authors:  Marie Pancera; Jason S McLellan; Xueling Wu; Jiang Zhu; Anita Changela; Stephen D Schmidt; Yongping Yang; Tongqing Zhou; Sanjay Phogat; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

Review 2.  Therapeutic proteins.

Authors:  Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

3.  Sequencing antibody repertoires: the next generation.

Authors:  Nicolas Fischer
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

4.  A systems approach to HIV-1 vaccines.

Authors:  Tianlei Ying; Ponraj Prabakaran; Dimiter S Dimitrov
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

Review 5.  Cancer immunotherapy: a promising dawn in cancer research.

Authors:  Banashree Bondhopadhyay; Sandeep Sisodiya; Atul Chikara; Asiya Khan; Pranay Tanwar; Dil Afroze; Neha Singh; Usha Agrawal; Ravi Mehrotra; Showket Hussain
Journal:  Am J Blood Res       Date:  2020-12-15

6.  Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.

Authors:  Zhongyu Zhu; Haiyan Rebekah Qin; Weizao Chen; Qi Zhao; Xiaoying Shen; Robert Schutte; Yanping Wang; Gilad Ofek; Emily Streaker; Ponraj Prabakaran; Genevieve G Fouda; Hua-Xin Liao; John Owens; Mark Louder; Yongping Yang; Kristina-Ana Klaric; M Anthony Moody; John R Mascola; Jamie K Scott; Peter D Kwong; David Montefiori; Barton F Haynes; Georgia D Tomaras; Dimiter S Dimitrov
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

8.  Local and global anatomy of antibody-protein antigen recognition.

Authors:  Meryl Wang; David Zhu; Jianwei Zhu; Ruth Nussinov; Buyong Ma
Journal:  J Mol Recognit       Date:  2017-12-08       Impact factor: 2.137

9.  Characterization of human IgG repertoires in an acute HIV-1 infection.

Authors:  Weizao Chen; Ponraj Prabakaran; Zhongyu Zhu; Yang Feng; Emily D Streaker; Dimiter S Dimitrov
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

10.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.